Recruitment and participant flow
All patients with an HbA1c value of ≥8.0 at baseline and complete values at T0 and T4 for the primary analyses (decision shared/non-shared, socio-demographics, HbA1c goal, measured HbA1c, insulin vs. no insulin) were included (n = 547; see Additional file 1: flow chart).